The other 3 R’s – understanding method risk, robustness and ruggedness

About The Event

In the first webinar of the series Dr. Steve Ward-Smith will walk you through the key aspects to consider when developing reliable, repeatable pharmaceutical methods for particle size assessment. He will explain a simple step-by-step way to identify which factors really matter for your sample and how to assess the risks associated with each one. He will go through case studies which will show how taking the time to build a strong method from the start pays off – helping you avoid problems during method transfer, reducing day-to-day issues in the lab and minimizing the need for ongoing maintenance. Finally, Steve will highlight common aspects when developing for assessment of other CMAs (solid form, elemental impurities, particle shape, etc.).